Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2646-2654

  De Caterina, Raffaele ^a,b   Basta, Giuseppina ^a   Lazzerini, Guido ^a   Dell'Omo, Giulia ^a   Petrucci, Roberta ^a   Morale, Marco ^a   Carmassi, Franco ^a   Pedrinelli, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; Intima media thickness; Soluble ICAM 1; Soluble VCAM 1

Indexed keywords

ALBUMIN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INTIMA; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SMOKING;

EID: 0031471945     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2646     Document Type: Article

References (20)

1. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
2. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager M, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B-74B.
3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
4. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93:50-55.
5. 2-antiplasmin in peripheral arterial disease. Thromb Haemost. 1984;52:240-242.
6. Blann AD, McCollum CN. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg. 1994;8:10-15.
7. Boehme MW, Nawroth PP, Kling E, Lin J, Amiral J, Riedesel J, Raeth U, Scherbaum WA. Serum thrombomodulin: a novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1994;37:572-577.
8. Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol. 1994;101:109-113.
9. Ohdama S, Matsubara O, Aoki N. Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries. Chest. 1994;106:666-671.
10. Hsu CS, Chan DW, Iriye B, Johnson TR, Hong SF, Petri M. Plasma thrombomodulin levels in women with systemic lupus erythematosus. Am J Perinatol. 1995;12:27-29.
11. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non diabetic subjects. Lancet. 1988;2:530-533.
12. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 1989;32:219-226.
13. Blann AD, Naqvi T, Waite M, McCollum CM. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 1993;7:107-111.
14. Tse WY, Maxwell SRJ, Thomason H, Blann A, Thorpe GHG, Waite M, Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens. 1994;8:843-849.
15. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 1990;227:273-278.
16. Nordby G, Haaland A, Os I. Evidence of decreased fibrinolytic activity in hypertensive premenopausal women. Scand J Clin Lab Invest. 1992;52:275-281.
17. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994;344:14-18.
18. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
19. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13:197-204.
20. O'Brien KD, Allen MD, Me Donald TO, Chait A, Harlan KM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. Circulation. 1993;92:945-951.